Did These 5 Stocks Miss or Beat Analyst Expectations?

  Google+ | + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.48 in the quarter versus EPS of $-0.19 in the year-earlier quarter. Revenue Was the same at $200,000 as the year-earlier quarter.

ZIOPHARM Oncology, Inc. reported adjusted EPS loss of $0.48 per share. By that measure, the company missed the mean analyst estimate of $-0.29. It beat the average revenue estimate of $0.

The stock market is at 5-year highs! Discover the best stocks to buy in today’s market. CLICK HERE for Your Stock Investor Cheat Sheet NOW!

ZIOP

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business